Emerging Coagulation Tests and Suppliers Developing New Technologies
US$ 1,480.00
The report presents an overview of the clinical significance and market needs for major coagulation laboratory tests, as well as extensive listings of companies developing or marketing new coagulation technologies and products. Contains 125 pages and 20 tables
December 2011
125 pages
Emerging Cancer Molecular Diagnostic Tests
US$ 1,160.00
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing. Contains 45 pages and 1 table
December 2011
45 pages
Aloka in the Global Diagnostic Imaging Sector
US$ 1,520.00
A strategic assessment of Aloka, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
November 2011
32 pages
Global Agrochemical Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
US$ 10,000.00
... well as over 100 syndicated multi-client studies and numerous proprietary single-client assignments. This database contains information on major agrochemical companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the Top 10 companies’ product and financial literature ...
November 2011
400 pages
Global Diagnostic Imaging Companies Financial Performance
US$ 1,960.00
Each company’s analysis provides: Sales estimates by division, geographic region, and modality. Five-year sales and operating profit performance. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 92 pages and 78 tables
November 2011
92 pages
Global Diagnostic Imaging Companies M&A, Business Organizations, and Senior Management
US$ 1,480.00
... , divestitures, and significant organizational changes. Current organizational structure. Management philosophy and attitudes toward the diagnostic imaging market. Background of key executives. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, ...
November 2011
92 pages
Global Diagnostic Imaging Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
US$ 10,000.00
... , factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a-vis the leading competitors. ...
November 2011
850 pages
Global Diagnostic Imaging Companies Major Facilities and Employees
US$ 1,480.00
... , manufacturing, and R&D facilities in the U.S. and abroad. New plants under construction. U.S. and international work force size and distribution. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 32 pages
November 2011
32 pages
Global Diagnostic Imaging Companies R&D Pipeline and Expenditures
US$ 1,480.00
... , research facilities, and staff. New technologies, systems, and applications in development, including their specifications and anticipated introduction dates. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 40 pages
November 2011
40 pages
Global Flavor and Fragrance Companies Major Facilities and Employees
US$ 1,480.00
For each company, the report provides: Production, compounding, creative, and R&D facilities by country. Workforce size. The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise, and Takasago. Contains 52 pages
November 2011
52 pages
Global Paint and Coatings Companies Financial Performance
US$ 1,480.00
... Sales by division, geographic region and product line. Five-year sales and operating profit performance. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 75 ...
November 2011
75 pages
Global Paint and Coatings Companies Joints Ventures and Collaborations
US$ 1,480.00
... licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. ...
November 2011
40 pages
Global Paint and Coatings Companies M&A, Business Organizations, and Senior Management
US$ 1,480.00
... , the report provides: History of the company paints and coatings business evolution, which is important to understanding the corporate culture, management mentality, ... in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 80 pages ...
November 2011
80 pages
Global Paint and Coatings Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
US$ 10,160.00
... , factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading paints and coatings companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis leading competitors. To ...
November 2011
500 pages
Global Paint and Coatings Companies Product Portfolios
US$ 1,480.00
The report presents extensive review of the major paints and coatings companies product lines. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 50 pages
November 2011
50 pages
Global Paint and Coatings Companies R&D Pipeline and Expenditures
US$ 1,480.00
For each company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies and products in development. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 35 pages
November 2011
35 pages
The US AIDS Diagnostics Market: Test Volumes, Sales Forecasts, and Supplier Shares
US$ 1,480.00
Summary This report presents a detailed analysis of the US AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, HIV ... , Western Blot and other confirmatory tests performed in the following market segments: Hospitals Commercial/Private Laboratories Blood Banks Physician Offices ...
October 2011
251 pages
French AIDS Diagnostic Market: Test Volumes, Sales Forecasts, and Supplier Shares
US$ 1,000.00
Summary This report presents a detailed analysis of the French AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, ... /Private Laboratories Blood Banks Physician Offices Public Health Laboratories In addition to test volume and sales projections, the report presents sales and ...
October 2011
251 pages
The 2011 Global Animal Health Market Dynamics and Trends
US$ 1,400.00
The report provides a strategic overview of the worldwide animal health market, including: Five-year forecasts for: Major market segments. Key ... of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such ...
September 2011
12 pages
The 2011 Leading Animal Health Companies Strategic Directions
US$ 1,560.00
The companies analyzed in this report include Bayer, Boehringer Ingelhein, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol and Virbac. For each company, the report provides: Specific business, new product development and marketing strategies. Anticipated acquisitions, joint ventures and ...
September 2011
30 pages
The 2011 Leading Animal Health Companies Collaborative Arrangements
US$ 1,200.00
Each company analysis provides: Major joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort Dodge/Wyeth, Merial, Novartis, ...
September 2011
65 pages
The 2011 Leading Animal Health Companies Technological Know-How
US$ 1,520.00
Each company analysis provides: Internally developed and acquired animal health technologies, processes and related capabilities. Proprietary technologies and patent litigations. The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort Dodge/Wyeth, Merial, Novartis, Pfizer, Schering- ...
September 2011
30 pages
The 2011 Leading Animal Health Companies Product Portfolio Analyses
US$ 1,200.00
The companies analyzed in this report include Bayer, Boehringer Ingelheim, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol, and Virbac. For each company, the report provides: Extensive review of major product lines. Recently introduced products and line extensions. Contains 100 pages
September 2011
100 pages
The 2011 Leading Animal Health Companies Marketing Tactics
US$ 1,560.00
The companies analyzed in this report include Bayer, Boehringer Ingelheim, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol, and Virbac. For each company, the report provides: Sales force size in the U.S. and other markets. Promotional tactics. Distribution approaches. Product service and ...
September 2011
38 pages
The 2011 Leading Chemical Companies Facilities and Employees
US$ 1,480.00
... U.S. and abroad. Manufacturing practices. New plants under construction. U.S. and international work force size and distribution development. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 63 pages
September 2011
63 pages
The 2011 Leading Chemical Companies R&D Expenditures and Major Programs
US$ 2,000.00
... company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 44 pages
September 2011
44 pages
The 2011 Leading Chemical Companies Collaborative Arrangements
US$ 1,480.00
... ventures, distribution, OEM and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 52 pages
September 2011
52 pages
The 2011 Leading Chemical Companies Business Organizations and Senior Management Profiles
US$ 1,480.00
... . Recent acquisitions, divestitures and significant organizational changes. Current organizational structure. Background of key executives. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 125 pages
September 2011
125 pages
The 2011 Leading Food and Beverage Companies Strengths, Weaknesses and Strategic Directions
US$ 1,480.00
For each company, the report provides: Specific business, new product development and marketing objectives and strategies. Strengths and weaknesses. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, Nestle, ...
September 2011
45 pages
The 2011 Leading Food and Beverage Companies Major Facilities and Employees
US$ 1,480.00
For each company, the report provides: Major administrative, manufacturing, and R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. The U.S. and international workforce. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, ...
September 2011
40 pages
The 2011 Leading Food and Beverage Companies Product Portfolio Analyses
US$ 1,480.00
For each company, the report presents: Extensive review of major product lines. Recent new product introductions and line extensions. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, Nestle, PepsiCo, Tyson, and Unilever. Contains 90 pages
September 2011
90 pages
The 2011 Leading Food and Beverage Companies Marketing Tactics
US$ 1,480.00
For each company, the analysis presents: Sales force in the U.S. and international markets. Distribution strategies. Promotional tactics. Innovative packaging approaches. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, Nestle, PepsiCo, Tyson, and Unilever. ...
September 2011
65 pages
The 2011 Leading Food and Beverage Companies Collaborations
US$ 1,480.00
For each company, the analysis presents: Major joint ventures, product development and marketing partners. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, Nestle, PepsiCo, Tyson, and Unilever. ...
September 2011
45 pages
Emerging Infectious Disease Testing Technologies and Market Applications
US$ 760.00
This report provides a detailed analysis of the current and emerging technologies, and their potential applications for the infectious disease testing market, including DNA probes, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several ...
September 2011
61 pages
The 2011 Global Orthopedics Market Dynamics and Trends
US$ 1,480.00
... categories. In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc. The analysis of major ...
September 2011
53 pages
The 2011 Leading Orthopedics Companies Collaborative Arrangements
US$ 1,480.00
... ventures, distribution, O.E.M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 42 ...
September 2011
42 pages
The 2011 Leading Orthopedics Companies Product Portfolio Analyses
US$ 1,400.00
Each company's analysis provides: Review of major product lines. Specifications and features of current products. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 158 pages
September 2011
158 pages
The 2011 Global Pharmaceutical Market Dynamics and Trends
US$ 1,480.00
A 25-page worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for key geographic regions: North America, Europe, Japan, Latin America. Sales ...
September 2011
25 pages
North American Chemical Market: Strategic Assessments of Leading Suppliers
US$ 11,600.00
... , annually updated and cost-effective information base on performance, capabilities, goals and strategies of the leading players in the North American chemical market. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors. ...
September 2011
828 pages
European Chemical Market: Strategic Assessments of Leading Suppliers
US$ 11,600.00
... updated and cost-effective information base on performance, capabilities, goals and strategies of the leading players in the European chemical market. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors. To assist ...
September 2011
828 pages
Asia Pacific Chemical Market: Strategic Assessments of Leading Suppliers
US$ 11,600.00
... , annually updated and cost-effective information base on performance, capabilities, goals and strategies of the leading players in the Asia Pacific chemical market. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors. To ...
September 2011
828 pages
